Riskpilot← Back to searchSign inGet full accessNordic Herbs Oy
OYActiveY-tunnus 2701178-9Kiviniityntie 14Growing of spices, aromatic, drug and pharmaceutical crops · NACE 0128Est. 2015— employees
Revenue 2024
EUR 680K
+59% vs 2023
EBITDA margin
8.7%
-3% vs 2023
Equity ratio
11.0%
Financial strength
Net profit 2024
EUR 4K
-4% vs 2023
| Revenue | EUR 680K | +59% |
| EBITDA | EUR 59K | -3% |
| Net profit | EUR 4K | -4% |
| Total assets | EUR 471K | -3% |
| Equity | EUR 52K | +150% |
| Employees | — | — |
Legal name
Nordic Herbs Oy
Y-tunnus number
2701178-9
Legal form
Osakeyhtiö
NACE code
0128 · Growing of spices, aromatic, drug and pharmaceutical crops
Founded
19. heinäkuuta 2015
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Company purpose
10830 Teen ja kahvin valmistus,
10840 Mausteiden ja maustekastikkeiden valmistus,
10610 Myllytuotteiden valmistus,
463 Elintarvikkeiden, juomien ja tupakan tukkukauppa,
4791 Vähittäiskauppa postimyyntiliikkeiden tai Internetin välityksellä,
sekä kaikki laillinen liiketoiminta.
Address
Kiviniityntie 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 159 | 354 | 509 | 428 | 680 |
| Staff expenses | −41 | −137 | −144 | −126 | −123 |
| EBITDA | 4 | 33 | 53 | 61 | 59 |
| Depreciation & amort. | — | −18 | −40 | −37 | −33 |
| EBIT | 4 | 15 | 13 | 23 | 26 |
| Net financials | −3 | −5 | −10 | −18 | −21 |
| Profit before tax | 0 | 10 | 3 | 5 | 5 |
| Tax | −0 | 10 | 1 | 1 | 1 |
| Net profit | 0 | −1 | 2 | 4 | 4 |
| Item | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 168 | 356 | 508 | 485 | 471 |
| Equity | 26 | 10 | 17 | 21 | 52 |
| Long-term debt | 107 | 150 | 247 | 274 | 229 |
| Short-term debt | 36 | 195 | 244 | 191 | 191 |
| Total debt | 143 | 346 | 491 | 465 | 419 |
EBITDA margin
8.7%
This company
15.8%
Market median
-45% vs market
20192024
Equity ratio
11.0%
This company
38.2%
Market median
-71% vs market
20192024
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20192024
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20192024
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20192024
Debt / equity
8.11×
This company
0.62×
Market median
-1208% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-10-01 – 2021-09-30
- Annual report 2019Filed via PRH / YTJ · Period 2018-10-01 – 2019-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PM Deputy Member | Deputy Member | 2015 |
PJ Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2025 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordic Herbs Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pasi Markus Kuusela | Deputy Member | 0 companies |
| Petri Juhani Koivisto | Chief Executive Officer | 0 companies |
| Keir Cornelius | Board of Directors | 0 companies |
| Sari Hannele Koivisto | Board of Directors | 0 companies |
| Risto Samuli Kuusisto | Board of Directors | 0 companies |